UniProt ID | MARE2_HUMAN | |
---|---|---|
UniProt AC | Q15555 | |
Protein Name | Microtubule-associated protein RP/EB family member 2 | |
Gene Name | MAPRE2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 327 | |
Subcellular Localization | Cytoplasm, cytoskeleton . Associated with the microtubule network. Accumulates at the plus end of microtubules. | |
Protein Description | May be involved in microtubule polymerization, and spindle function by stabilizing microtubules and anchoring them at centrosomes. May play a role in cell migration (By similarity).. | |
Protein Sequence | MPGPTQTLSPNGENNNDIIQDNNGTIIPFRKHTVRGERSYSWGMAVNVYSTSITQETMSRHDIIAWVNDIVSLNYTKVEQLCSGAAYCQFMDMLFPGCISLKKVKFQAKLEHEYIHNFKLLQASFKRMNVDKVIPVEKLVKGRFQDNLDFIQWFKKFYDANYDGKEYDPVEARQGQDAIPPPDPGEQIFNLPKKSHHANSPTAGAAKSSPAAKPGSTPSRPSSAKRASSSGSASKSDKDLETQVIQLNEQVHSLKLALEGVEKERDFYFGKLREIELLCQEHGQENDDLVQRLMDILYASEEHEGHTEEPEAEEQAHEQQPPQQEEY | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 (in isoform 5) | Acetylation | - | 58.43 | 22814378 | |
5 | Phosphorylation | ---MPGPTQTLSPNG ---CCCCCCCCCCCC | 39.85 | 29255136 | |
7 | Phosphorylation | -MPGPTQTLSPNGEN -CCCCCCCCCCCCCC | 31.51 | 23401153 | |
9 | Phosphorylation | PGPTQTLSPNGENNN CCCCCCCCCCCCCCC | 21.51 | 23401153 | |
25 | Phosphorylation | IIQDNNGTIIPFRKH CEECCCCCEEECCCC | 20.18 | 26074081 | |
33 | Phosphorylation | IIPFRKHTVRGERSY EEECCCCEECCEECC | 18.22 | - | |
39 | Phosphorylation | HTVRGERSYSWGMAV CEECCEECCEEEEEE | 21.15 | 29978859 | |
40 | Phosphorylation | TVRGERSYSWGMAVN EECCEECCEEEEEEE | 18.05 | 29978859 | |
41 | Phosphorylation | VRGERSYSWGMAVNV ECCEECCEEEEEEEE | 20.57 | 29978859 | |
49 | Phosphorylation | WGMAVNVYSTSITQE EEEEEEEEECCCCHH | 10.88 | 29978859 | |
50 | Phosphorylation | GMAVNVYSTSITQET EEEEEEEECCCCHHH | 16.05 | 28851738 | |
51 | Phosphorylation | MAVNVYSTSITQETM EEEEEEECCCCHHHH | 13.37 | 27732954 | |
52 | Phosphorylation | AVNVYSTSITQETMS EEEEEECCCCHHHHC | 20.07 | 27732954 | |
54 | Phosphorylation | NVYSTSITQETMSRH EEEECCCCHHHHCHH | 21.81 | 28851738 | |
57 | Phosphorylation | STSITQETMSRHDII ECCCCHHHHCHHHHH | 15.61 | 28851738 | |
59 | Phosphorylation | SITQETMSRHDIIAW CCCHHHHCHHHHHHH | 33.61 | 28851738 | |
76 | Ubiquitination | DIVSLNYTKVEQLCS HHHCCCCCCHHHHHC | 27.78 | - | |
83 | Ubiquitination | TKVEQLCSGAAYCQF CCHHHHHCCHHHHHH | 39.81 | - | |
89 | Ubiquitination | CSGAAYCQFMDMLFP HCCHHHHHHHHHHCC | 24.83 | - | |
95 | Ubiquitination | CQFMDMLFPGCISLK HHHHHHHCCCCEEEC | 3.82 | - | |
98 | Ubiquitination | MDMLFPGCISLKKVK HHHHCCCCEEECEEE | 1.62 | - | |
102 | Ubiquitination | FPGCISLKKVKFQAK CCCCEEECEEEEEEE | 49.05 | 21890473 | |
109 | Acetylation | KKVKFQAKLEHEYIH CEEEEEEECCCHHHH | 43.56 | 26051181 | |
109 | Ubiquitination | KKVKFQAKLEHEYIH CEEEEEEECCCHHHH | 43.56 | - | |
112 | Ubiquitination | KFQAKLEHEYIHNFK EEEEECCCHHHHHHH | 43.53 | - | |
113 | Ubiquitination | FQAKLEHEYIHNFKL EEEECCCHHHHHHHH | 36.49 | - | |
119 | Ubiquitination | HEYIHNFKLLQASFK CHHHHHHHHHHHHHH | 54.31 | - | |
119 | Acetylation | HEYIHNFKLLQASFK CHHHHHHHHHHHHHH | 54.31 | 25953088 | |
122 | Ubiquitination | IHNFKLLQASFKRMN HHHHHHHHHHHHHCC | 45.45 | - | |
124 | Phosphorylation | NFKLLQASFKRMNVD HHHHHHHHHHHCCCC | 20.52 | 30108239 | |
126 | Acetylation | KLLQASFKRMNVDKV HHHHHHHHHCCCCCE | 48.52 | 25953088 | |
126 | Malonylation | KLLQASFKRMNVDKV HHHHHHHHHCCCCCE | 48.52 | 26320211 | |
126 | Ubiquitination | KLLQASFKRMNVDKV HHHHHHHHHCCCCCE | 48.52 | - | |
132 | Ubiquitination | FKRMNVDKVIPVEKL HHHCCCCCEEEHHHH | 37.47 | - | |
138 | Acetylation | DKVIPVEKLVKGRFQ CCEEEHHHHHCCCCC | 59.83 | 25953088 | |
138 | Ubiquitination | DKVIPVEKLVKGRFQ CCEEEHHHHHCCCCC | 59.83 | - | |
141 | Ubiquitination | IPVEKLVKGRFQDNL EEHHHHHCCCCCCCC | 55.60 | - | |
143 | Ubiquitination | VEKLVKGRFQDNLDF HHHHHCCCCCCCCHH | 21.97 | 21890473 | |
143 | Ubiquitination | VEKLVKGRFQDNLDF HHHHHCCCCCCCCHH | 21.97 | 21890473 | |
151 | Ubiquitination | FQDNLDFIQWFKKFY CCCCCHHHHHHHHHH | 3.37 | - | |
155 (in isoform 1) | Ubiquitination | - | 38.73 | 21890473 | |
155 (in isoform 2) | Ubiquitination | - | 38.73 | 21890473 | |
155 | Ubiquitination | LDFIQWFKKFYDANY CHHHHHHHHHHCCCC | 38.73 | 21890473 | |
156 | Ubiquitination | DFIQWFKKFYDANYD HHHHHHHHHHCCCCC | 39.42 | - | |
158 | Phosphorylation | IQWFKKFYDANYDGK HHHHHHHHCCCCCCC | 24.03 | 29496907 | |
162 | Phosphorylation | KKFYDANYDGKEYDP HHHHCCCCCCCCCCC | 28.00 | 29978859 | |
165 | Ubiquitination | YDANYDGKEYDPVEA HCCCCCCCCCCCCHH | 50.64 | - | |
165 | Sumoylation | YDANYDGKEYDPVEA HCCCCCCCCCCCCHH | 50.64 | - | |
167 | Phosphorylation | ANYDGKEYDPVEARQ CCCCCCCCCCCHHCC | 29.09 | 25159151 | |
193 | Ubiquitination | EQIFNLPKKSHHANS HHHCCCCCCCCCCCC | 70.81 | - | |
194 | Ubiquitination | QIFNLPKKSHHANSP HHCCCCCCCCCCCCC | 53.75 | - | |
195 | Phosphorylation | IFNLPKKSHHANSPT HCCCCCCCCCCCCCC | 26.99 | 29691806 | |
200 | Phosphorylation | KKSHHANSPTAGAAK CCCCCCCCCCCCCCC | 25.14 | 25159151 | |
202 | Phosphorylation | SHHANSPTAGAAKSS CCCCCCCCCCCCCCC | 37.23 | 28176443 | |
207 | Ubiquitination | SPTAGAAKSSPAAKP CCCCCCCCCCCCCCC | 51.43 | - | |
208 | Phosphorylation | PTAGAAKSSPAAKPG CCCCCCCCCCCCCCC | 36.51 | 23401153 | |
209 | Phosphorylation | TAGAAKSSPAAKPGS CCCCCCCCCCCCCCC | 20.18 | 25159151 | |
213 | Ubiquitination | AKSSPAAKPGSTPSR CCCCCCCCCCCCCCC | 52.60 | - | |
213 | Acetylation | AKSSPAAKPGSTPSR CCCCCCCCCCCCCCC | 52.60 | 25953088 | |
216 | Phosphorylation | SPAAKPGSTPSRPSS CCCCCCCCCCCCCCC | 45.75 | 23401153 | |
216 | O-linked_Glycosylation | SPAAKPGSTPSRPSS CCCCCCCCCCCCCCC | 45.75 | 28411811 | |
217 | Phosphorylation | PAAKPGSTPSRPSSA CCCCCCCCCCCCCCC | 31.06 | 25159151 | |
218 | Ubiquitination | AAKPGSTPSRPSSAK CCCCCCCCCCCCCCC | 30.00 | 21890473 | |
219 | Phosphorylation | AKPGSTPSRPSSAKR CCCCCCCCCCCCCCC | 57.84 | 25159151 | |
222 | Phosphorylation | GSTPSRPSSAKRASS CCCCCCCCCCCCCCC | 41.64 | 25159151 | |
223 | Phosphorylation | STPSRPSSAKRASSS CCCCCCCCCCCCCCC | 40.26 | 25159151 | |
225 | Acetylation | PSRPSSAKRASSSGS CCCCCCCCCCCCCCC | 50.90 | 12435305 | |
228 | Acetylation | PSSAKRASSSGSASK CCCCCCCCCCCCCCC | 29.12 | - | |
228 | Ubiquitination | PSSAKRASSSGSASK CCCCCCCCCCCCCCC | 29.12 | - | |
228 | Phosphorylation | PSSAKRASSSGSASK CCCCCCCCCCCCCCC | 29.12 | 26657352 | |
229 | Phosphorylation | SSAKRASSSGSASKS CCCCCCCCCCCCCCC | 37.42 | 23401153 | |
230 | Phosphorylation | SAKRASSSGSASKSD CCCCCCCCCCCCCCC | 33.98 | 29978859 | |
232 | Phosphorylation | KRASSSGSASKSDKD CCCCCCCCCCCCCHH | 31.17 | 28464451 | |
234 | Phosphorylation | ASSSGSASKSDKDLE CCCCCCCCCCCHHHH | 34.10 | 18669648 | |
235 | Ubiquitination | SSSGSASKSDKDLET CCCCCCCCCCHHHHH | 63.49 | - | |
236 | Phosphorylation | SSGSASKSDKDLETQ CCCCCCCCCHHHHHH | 47.61 | 28464451 | |
238 | Acetylation | GSASKSDKDLETQVI CCCCCCCHHHHHHHH | 71.89 | 25953088 | |
238 | Ubiquitination | GSASKSDKDLETQVI CCCCCCCHHHHHHHH | 71.89 | - | |
242 | Phosphorylation | KSDKDLETQVIQLNE CCCHHHHHHHHHHHH | 35.12 | 28464451 | |
253 | Phosphorylation | QLNEQVHSLKLALEG HHHHHHHHHHHHHHH | 28.48 | 30576142 | |
255 | Ubiquitination | NEQVHSLKLALEGVE HHHHHHHHHHHHHHH | 34.43 | - | |
259 | Ubiquitination | HSLKLALEGVEKERD HHHHHHHHHHHHHHH | 56.43 | 21890473 | |
259 | Ubiquitination | HSLKLALEGVEKERD HHHHHHHHHHHHHHH | 56.43 | 21890473 | |
263 | Ubiquitination | LALEGVEKERDFYFG HHHHHHHHHHHCHHH | 56.49 | - | |
263 | Acetylation | LALEGVEKERDFYFG HHHHHHHHHHHCHHH | 56.49 | 25953088 | |
271 | Acetylation | ERDFYFGKLREIELL HHHCHHHHHHHHHHH | 34.18 | 23236377 | |
271 | Ubiquitination | ERDFYFGKLREIELL HHHCHHHHHHHHHHH | 34.18 | 21890473 | |
271 (in isoform 1) | Ubiquitination | - | 34.18 | 21890473 | |
327 | Phosphorylation | QPPQQEEY------- CCCCCCCC------- | 24.09 | 27642862 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
236 | S | Phosphorylation | Kinase | CSNK2A1 | P68400 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of MARE2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of MARE2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NIF3L_HUMAN | NIF3L1 | physical | 16189514 | |
MARE2_HUMAN | MAPRE2 | physical | 16189514 | |
MARE3_HUMAN | MAPRE3 | physical | 16189514 | |
APC_HUMAN | APC | physical | 11470413 | |
A4_HUMAN | APP | physical | 21832049 | |
MARE2_HUMAN | MAPRE2 | physical | 25416956 | |
MARE1_HUMAN | MAPRE1 | physical | 25416956 | |
PAXI1_HUMAN | PAXIP1 | physical | 25416956 | |
THIOM_HUMAN | TXN2 | physical | 25416956 | |
CRAC1_HUMAN | CRTAC1 | physical | 25416956 | |
MCM6_HUMAN | MCM6 | physical | 26344197 | |
HSF1_HUMAN | HSF1 | physical | 27173435 | |
TC1D2_HUMAN | TCTEX1D2 | physical | 27173435 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-271, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-9, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-208 AND SER-219, ANDMASS SPECTROMETRY. | |
"Phosphoproteome of resting human platelets."; Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.; J. Proteome Res. 7:526-534(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-200, AND MASSSPECTROMETRY. | |
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry."; Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.; Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-219 AND SER-223, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-200, AND MASSSPECTROMETRY. | |
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-167, AND MASSSPECTROMETRY. |